Matthew Strobeck - Insider Trading & Ownership

Location
C/O Metabolix, Inc., 21 Erie Street, Cambridge, MA
Summary
The estimated net worth of Matthew Strobeck is at least $11.9M dollars as of June 2, 2025. Matthew Strobeck is the Director of BIODESIX INC and owns shares of BIODESIX INC (BDSX) stock worth about $7.46M. Matthew Strobeck is the Director of Accelerate Diagnostics, Inc and owns shares of Accelerate Diagnostics, Inc (AXDX) stock worth about $2.47M. Matthew Strobeck is the Director of QuidelOrtho Corp and owns shares of QuidelOrtho Corp (QDEL) stock worth about $2.02M.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck
All Insider Reports
All Insider Reports

Ownership of Matthew Strobeck

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BDSX BIODESIX INC Director $7.46M May 20, 2025
AXDX Accelerate Diagnostics, Inc Director $2.47M Jan 23, 2024
QDEL QuidelOrtho Corp Director $2.02M May 29, 2025
QDEL QUIDEL CORP /DE/ Director May 27, 2022

Insider Transactions Reported by Matthew Strobeck:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.